Total medical devices industry M&A deals in Q3 2019 worth $7.43bn were announced in the US, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 45.1% over the previous quarter and a drop of 5.3% when compared with the last four-quarter average of $7.87bn.
The US held a 91.5% share of the global medical devices industry M&A deal value that totalled $8.11bn in Q3 2019.
In terms of deal activity, the US recorded 52 deals during Q3 2019, marking a drop of 1.9% over the previous quarter and a flat growth over the last four-quarter average.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe US medical devices industry M&A deals in Q3 2019: Top deals
The top five medical devices industry M&A deals accounted for 85.4% of the overall value during Q3 2019.
The combined value of the top five medical devices M&A deals stood at $6.34bn, against the overall value of $7.43bn recorded for the month.
The top five medical devices industry deals of Q3 2019 tracked by GlobalData were:
1) Exact Sciences’ $2.8bn acquisition of Genomic Health
2) The $1.17bn acquisition of BioTek Instruments by Agilent Technologies
3) Siemens Healthineers’ $1.1bn acquisition of Corindus Vascular Robotics
4) The $775m acquisition of Hu-Friedy Manufacturing by Cantel Medical
5) Stryker‘s acquisition of GYS Tech and Mobius Imaging for $500m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.
